| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 7 | 2025 | 59 | 2.680 |
Why?
|
| Vasospasm, Intracranial | 3 | 2025 | 18 | 1.800 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 215 | 1.280 |
Why?
|
| Neurosurgical Procedures | 7 | 2026 | 230 | 1.200 |
Why?
|
| Brain Ischemia | 2 | 2022 | 87 | 1.100 |
Why?
|
| Intracranial Aneurysm | 7 | 2026 | 63 | 1.090 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 997 | 1.030 |
Why?
|
| Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 2 | 0.870 |
Why?
|
| Neurosurgeons | 2 | 2021 | 22 | 0.840 |
Why?
|
| Neurosurgery | 2 | 2021 | 76 | 0.760 |
Why?
|
| Stroke | 3 | 2022 | 260 | 0.750 |
Why?
|
| Pandemics | 2 | 2020 | 199 | 0.720 |
Why?
|
| Human Activities | 1 | 2021 | 6 | 0.720 |
Why?
|
| Time | 1 | 2021 | 16 | 0.720 |
Why?
|
| Terminology as Topic | 1 | 2021 | 64 | 0.680 |
Why?
|
| Humans | 43 | 2026 | 28851 | 0.680 |
Why?
|
| Brain Mapping | 4 | 2025 | 207 | 0.680 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 34 | 0.640 |
Why?
|
| Betacoronavirus | 1 | 2020 | 39 | 0.630 |
Why?
|
| Embolization, Therapeutic | 4 | 2017 | 48 | 0.620 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.610 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 53 | 0.610 |
Why?
|
| Hypertension | 1 | 2022 | 309 | 0.600 |
Why?
|
| Mechanical Thrombolysis | 1 | 2017 | 3 | 0.520 |
Why?
|
| Stents | 4 | 2026 | 121 | 0.520 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 93 | 0.480 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 11 | 0.460 |
Why?
|
| Polyvinyls | 1 | 2015 | 14 | 0.460 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2015 | 16 | 0.450 |
Why?
|
| Endovascular Procedures | 3 | 2026 | 74 | 0.450 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 27 | 0.450 |
Why?
|
| Middle Aged | 17 | 2026 | 7414 | 0.450 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 146 | 0.420 |
Why?
|
| Microsurgery | 4 | 2026 | 50 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2025 | 841 | 0.410 |
Why?
|
| Aged | 12 | 2026 | 5598 | 0.360 |
Why?
|
| Treatment Outcome | 8 | 2026 | 2426 | 0.350 |
Why?
|
| Middle Cerebral Artery | 3 | 2026 | 54 | 0.350 |
Why?
|
| Female | 18 | 2025 | 15624 | 0.350 |
Why?
|
| Personal Protective Equipment | 2 | 2021 | 14 | 0.340 |
Why?
|
| Archaeology | 2 | 2021 | 59 | 0.340 |
Why?
|
| Retrospective Studies | 7 | 2024 | 2635 | 0.320 |
Why?
|
| Aneurysm, False | 2 | 2022 | 19 | 0.320 |
Why?
|
| Adult | 11 | 2026 | 8024 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2024 | 481 | 0.300 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2008 | 3 | 0.290 |
Why?
|
| Male | 17 | 2025 | 13921 | 0.290 |
Why?
|
| Postoperative Complications | 3 | 2023 | 634 | 0.280 |
Why?
|
| Brain | 3 | 2025 | 769 | 0.280 |
Why?
|
| Orbit | 2 | 2026 | 12 | 0.270 |
Why?
|
| Glioma | 2 | 2025 | 122 | 0.260 |
Why?
|
| Mitral Valve | 2 | 2024 | 63 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 224 | 0.250 |
Why?
|
| Cerebral Angiography | 4 | 2017 | 38 | 0.250 |
Why?
|
| Obesity | 2 | 2023 | 699 | 0.250 |
Why?
|
| Thyrotoxicosis | 1 | 2026 | 1 | 0.250 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2026 | 4 | 0.250 |
Why?
|
| Muscle Hypotonia | 1 | 2026 | 4 | 0.250 |
Why?
|
| Muscular Atrophy | 1 | 2026 | 33 | 0.240 |
Why?
|
| Achondroplasia | 1 | 2005 | 2 | 0.240 |
Why?
|
| Arachnoid Cysts | 1 | 2005 | 4 | 0.240 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 10 | 0.240 |
Why?
|
| Hernia | 1 | 2005 | 9 | 0.240 |
Why?
|
| Thrombectomy | 2 | 2016 | 30 | 0.240 |
Why?
|
| Syringomyelia | 1 | 2005 | 9 | 0.240 |
Why?
|
| Nimodipine | 1 | 2025 | 7 | 0.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2026 | 81 | 0.230 |
Why?
|
| Calcium Channel Blockers | 1 | 2025 | 41 | 0.230 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 312 | 0.230 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2024 | 6 | 0.220 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2024 | 3 | 0.220 |
Why?
|
| Patient Care Team | 1 | 2025 | 66 | 0.220 |
Why?
|
| Ventricular Septum | 1 | 2024 | 3 | 0.220 |
Why?
|
| Thyroid Neoplasms | 1 | 2025 | 39 | 0.220 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2024 | 173 | 0.220 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 23 | 0.220 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2024 | 16 | 0.220 |
Why?
|
| Laryngoscopes | 1 | 2024 | 1 | 0.220 |
Why?
|
| Laryngoscopy | 1 | 2024 | 6 | 0.220 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2024 | 5 | 0.220 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2024 | 43 | 0.210 |
Why?
|
| Nerve Net | 1 | 2025 | 112 | 0.210 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2022 | 36 | 0.210 |
Why?
|
| Intubation, Intratracheal | 1 | 2024 | 27 | 0.210 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 41 | 0.210 |
Why?
|
| Pediatrics | 1 | 2025 | 92 | 0.210 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2024 | 46 | 0.210 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 137 | 0.200 |
Why?
|
| Sinus of Valsalva | 1 | 2022 | 13 | 0.190 |
Why?
|
| Robotic Surgical Procedures | 1 | 2023 | 51 | 0.190 |
Why?
|
| Incidence | 1 | 2024 | 572 | 0.190 |
Why?
|
| Postoperative Period | 1 | 2022 | 68 | 0.180 |
Why?
|
| Drainage | 1 | 2022 | 45 | 0.180 |
Why?
|
| Aortic Valve | 1 | 2022 | 92 | 0.180 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2017 | 19 | 0.180 |
Why?
|
| Geology | 1 | 2021 | 2 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 115 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2021 | 49 | 0.180 |
Why?
|
| Natural Resources | 1 | 2021 | 1 | 0.180 |
Why?
|
| History, 20th Century | 1 | 2021 | 84 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 676 | 0.170 |
Why?
|
| Spinal Cord | 2 | 2015 | 214 | 0.170 |
Why?
|
| Patient Selection | 2 | 2015 | 150 | 0.170 |
Why?
|
| Canada | 1 | 2020 | 60 | 0.160 |
Why?
|
| Child | 4 | 2025 | 2287 | 0.160 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 12 | 0.160 |
Why?
|
| Workload | 1 | 2020 | 43 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 118 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 96 | 0.160 |
Why?
|
| Folic Acid | 1 | 2020 | 33 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2024 | 1280 | 0.160 |
Why?
|
| Neurocysticercosis | 1 | 2018 | 14 | 0.140 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 13 | 0.140 |
Why?
|
| Curriculum | 1 | 2020 | 303 | 0.140 |
Why?
|
| Hydrocephalus | 1 | 2018 | 55 | 0.130 |
Why?
|
| Neurons | 1 | 2020 | 297 | 0.130 |
Why?
|
| Vertebral Artery Dissection | 1 | 2017 | 4 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 2065 | 0.130 |
Why?
|
| Glasgow Outcome Scale | 1 | 2017 | 4 | 0.130 |
Why?
|
| Plasminogen Activators | 1 | 2017 | 7 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2020 | 250 | 0.130 |
Why?
|
| Risk Factors | 1 | 2022 | 2126 | 0.130 |
Why?
|
| Mobile Health Units | 1 | 2016 | 5 | 0.120 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2016 | 16 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 22 | 0.120 |
Why?
|
| Neuronavigation | 2 | 2026 | 13 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 24 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 22 | 0.120 |
Why?
|
| Triage | 1 | 2016 | 34 | 0.120 |
Why?
|
| Arteriovenous Malformations | 1 | 2015 | 16 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 41 | 0.120 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 11 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 26 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2015 | 36 | 0.110 |
Why?
|
| Disease Progression | 2 | 2015 | 477 | 0.110 |
Why?
|
| Executive Function | 1 | 2015 | 27 | 0.110 |
Why?
|
| United States | 1 | 2020 | 2222 | 0.110 |
Why?
|
| Aging | 2 | 2013 | 1016 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2015 | 274 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 28 | 0.100 |
Why?
|
| Motor Activity | 2 | 2013 | 148 | 0.100 |
Why?
|
| Cadaver | 3 | 2026 | 61 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 402 | 0.100 |
Why?
|
| Meningeal Neoplasms | 2 | 2011 | 73 | 0.100 |
Why?
|
| Meningioma | 2 | 2011 | 79 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 379 | 0.100 |
Why?
|
| Language | 1 | 2013 | 65 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2025 | 429 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 22 | 0.090 |
Why?
|
| Skull Base Neoplasms | 1 | 2011 | 22 | 0.090 |
Why?
|
| Thoracic Vertebrae | 2 | 2024 | 70 | 0.080 |
Why?
|
| Aneurysm | 2 | 2009 | 25 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2020 | 152 | 0.080 |
Why?
|
| Basilar Artery | 1 | 2008 | 7 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 14 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 130 | 0.070 |
Why?
|
| Ultrasonics | 1 | 2006 | 7 | 0.060 |
Why?
|
| Symporters | 1 | 2026 | 9 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 30 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2006 | 33 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2026 | 37 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 55 | 0.060 |
Why?
|
| Radiography | 1 | 2005 | 203 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2025 | 24 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2025 | 32 | 0.060 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2024 | 2 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2024 | 10 | 0.060 |
Why?
|
| Consensus | 1 | 2025 | 75 | 0.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 8 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1032 | 0.050 |
Why?
|
| Tooth Injuries | 1 | 2024 | 2 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2024 | 20 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2024 | 68 | 0.050 |
Why?
|
| Video Recording | 1 | 2024 | 40 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2024 | 40 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 76 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 49 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2024 | 40 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 138 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2023 | 16 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2024 | 81 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 245 | 0.050 |
Why?
|
| Analgesics | 1 | 2023 | 38 | 0.050 |
Why?
|
| Genistein | 1 | 2002 | 9 | 0.050 |
Why?
|
| Echocardiography, Doppler | 1 | 2022 | 21 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 62 | 0.050 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2013 | 14 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2024 | 631 | 0.050 |
Why?
|
| Aorta | 1 | 2022 | 124 | 0.050 |
Why?
|
| Quality of Life | 1 | 2026 | 521 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 118 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2022 | 139 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 222 | 0.040 |
Why?
|
| Arabia | 1 | 2021 | 1 | 0.040 |
Why?
|
| Mesopotamia | 1 | 2021 | 1 | 0.040 |
Why?
|
| Climate | 1 | 2021 | 33 | 0.040 |
Why?
|
| History, Ancient | 1 | 2021 | 35 | 0.040 |
Why?
|
| Conservation of Natural Resources | 1 | 2021 | 33 | 0.040 |
Why?
|
| Oxygen | 2 | 2013 | 237 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 74 | 0.040 |
Why?
|
| Pain | 1 | 2023 | 258 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 254 | 0.040 |
Why?
|
| Biodiversity | 1 | 2021 | 114 | 0.040 |
Why?
|
| Azacitidine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 360 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 35 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 22 | 0.040 |
Why?
|
| Axons | 1 | 2020 | 30 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 30 | 0.040 |
Why?
|
| Genome | 1 | 2020 | 56 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 190 | 0.040 |
Why?
|
| Ecosystem | 1 | 2021 | 228 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 554 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 404 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 685 | 0.030 |
Why?
|
| Reperfusion | 1 | 2016 | 7 | 0.030 |
Why?
|
| Remote Consultation | 1 | 2016 | 4 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 38 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 88 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 2833 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2016 | 43 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 123 | 0.030 |
Why?
|
| Semantics | 1 | 2013 | 11 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 916 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 1025 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 391 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Sphenoid Sinus | 1 | 2011 | 5 | 0.020 |
Why?
|
| Facial Bones | 1 | 2011 | 7 | 0.020 |
Why?
|
| Bacteria, Aerobic | 1 | 2011 | 4 | 0.020 |
Why?
|
| Skull Base | 1 | 2011 | 35 | 0.020 |
Why?
|
| Aneurysm, Ruptured | 1 | 2011 | 17 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 95 | 0.020 |
Why?
|
| Reaction Time | 1 | 2011 | 95 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2011 | 88 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 94 | 0.020 |
Why?
|
| Movement | 1 | 2011 | 100 | 0.020 |
Why?
|
| Electromyography | 1 | 2011 | 176 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2011 | 171 | 0.020 |
Why?
|
| Animals | 2 | 2020 | 10684 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 20 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cerebellum | 1 | 2009 | 41 | 0.020 |
Why?
|
| Consciousness Disorders | 1 | 2006 | 1 | 0.020 |
Why?
|
| Selection Bias | 1 | 2006 | 13 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2006 | 21 | 0.020 |
Why?
|
| Seizures | 1 | 2006 | 49 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 106 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 164 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 432 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 410 | 0.010 |
Why?
|
| Length of Stay | 1 | 2006 | 245 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 737 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 3193 | 0.010 |
Why?
|
| CpG Islands | 1 | 2002 | 26 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 77 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 588 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 377 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 1653 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 4802 | 0.010 |
Why?
|